236 results on '"Nakashima, Taku"'
Search Results
2. Lipocalin-2 as a prognostic marker in patients with acute exacerbation of idiopathic pulmonary fibrosis
3. Hypoxia-inducible factor 1α modulates interstitial pneumonia-mediated lung cancer progression
4. Nestin and Notch3 collaboratively regulate angiogenesis, collagen production, and endothelial–mesenchymal transition in lung endothelial cells
5. Preserved ratio impaired spirometry with or without restrictive spirometric abnormality
6. Prediction model for patient prognosis in idiopathic pulmonary fibrosis using hybrid radiomics analysis
7. Characteristic computed tomography features in mesenchymal-epithelial transition exon14 skipping-positive non-small cell lung cancer
8. High S100A9 level predicts poor survival, and the S100A9 inhibitor paquinimod is a candidate for treating idiopathic pulmonary fibrosis
9. Serum high-mobility group box 1 as a predictive marker for cytotoxic chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease
10. Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis
11. Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity
12. Prediction of radiation pneumonitis after definitive radiotherapy for locally advanced non-small cell lung cancer using multi-region radiomics analysis
13. Predictive role of circulatory HMGB1 in postoperative acute exacerbation of interstitial lung disease in lung cancer patients
14. Quantitative parameters of lymphocyte nuclear morphology in bronchoalveolar lavage fluid as novel biomarkers for sarcoidosis
15. Comparison of anti-aminoacyl-tRNA synthetase antibody-related and idiopathic non-specific interstitial pneumonia
16. Exhaled Nitric Oxide and Olfactory Dysfunction in Patients with Asthma: Association with Chronic Rhinosinusitis
17. Reduced endogenous secretory RAGE in blood and bronchoalveolar lavage fluid is associated with poor prognosis in idiopathic pulmonary fibrosis
18. Pulmonary arteriovenous malformation exhibiting recanalization >10 years after coil embolization: Two case reports
19. Association between Plasminogen Activator Inhibitor-1 and Osimertinib Tolerance in EGFR-Mutated Lung Cancer via Epithelial–Mesenchymal Transition
20. High preoperative C-reactive protein level is a risk factor for acute exacerbation of interstitial lung disease after non-pulmonary surgery
21. Serial measurements of KL-6 for monitoring activity and recurrence of interstitial pneumonia with anti-aminoacyl-tRNA synthetase antibody: A retrospective cohort study
22. Pneumonia and Meningoencephalitis Due to Varicella-zoster Virus Reinfection and Epstein-Barr Virus Reactivation in a Patient with Rheumatoid Arthritis
23. Association Between Patient Preference for Inhaler Medications and Asthma Outcomes
24. Association Between Patient Preference for Inhaler Medications and Asthma Outcomes
25. Mesenchymal-Specific Deletion of C/EBPβ Suppresses Pulmonary Fibrosis
26. Pulmonary Alveolar Proteinosis with Severe Respiratory Failure Improved by Segmental Lung Lavage with Fiberoptic Bronchoscopy under General Anesthesia
27. Additional file 1 of Characteristic computed tomography features in mesenchymal-epithelial transition exon14 skipping-positive non-small cell lung cancer
28. Chronic Hepatitis C Virus Infection is Associated with More Severe Asthma
29. First‐line osimertinib treatment in a patient with lung adenocarcinoma with coexisting epidermal growth factor receptorG719S and de novo T790M mutations
30. Primary Pulmonary Mucosa-associated Lymphoid Tissue Lymphoma with the High Expression of IgG4: A Case Report
31. Primary pulmonary extranodal NK/T-cell lymphoma diagnosed by thoracoscopic lung biopsy: A case report
32. Pneumatosis Intestinalis following Radiation Esophagitis during Chemoradiotherapy for Lung Cancer: A Case Report
33. Tolerability and efficacy of IMpower133 regimen modified for dialysis patients with extensive‐stage small cell lung cancer: Two case reports
34. Accelerated decline in lung function in adults with a history of remitted childhood asthma
35. MT95-4, a fully humanized antibody raised against aminopeptidase N, reduces tumor progression in a mouse model
36. MO10-2 Association of pre-existing interstitial lung abnormalities with immune checkpoint inhibitor-induced interstitial lung disease among patients with non-lung cancers
37. IL-18 binding protein can be a prognostic biomarker for idiopathic pulmonary fibrosis
38. Prognostic Significance of EGFR Gene Mutation in Patients With EGFR Mutated Non-small Cell Lung Cancer Who Received Best Supportive Care Alone
39. Additional file 3 of Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis
40. Additional file 5 of Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity
41. Additional file 9 of Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis
42. Additional file 7 of Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity
43. Additional file 1 of Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis
44. Additional file 4 of Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis
45. Additional file 2 of Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis
46. Additional file 1 of Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity
47. Additional file 6 of Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity
48. Additional file 4 of Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity
49. Additional file 8 of Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity
50. Additional file 3 of Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.